Shuttle Pharmaceuticals Holdings, Inc.SHPHNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank44
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P44
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | -8.00% |
| Q2 2025 | -34.84% |
| Q1 2025 | 59.56% |
| Q4 2024 | -29.57% |
| Q3 2024 | 116.90% |
| Q2 2024 | 10.17% |
| Q1 2024 | 35.48% |
| Q4 2023 | -58.61% |
| Q3 2023 | 24.48% |
| Q2 2023 | -8.91% |
| Q1 2023 | 726.25% |
| Q4 2022 | -83.32% |
| Q3 2022 | 697.73% |
| Q2 2022 | -71.66% |
| Q1 2022 | -33.07% |
| Q4 2021 | 136.48% |
| Q3 2021 | -34.80% |
| Q2 2021 | 170.51% |
| Q1 2021 | 0.00% |